Serological and Molecular Tests for COVID-19: a recent update

Area of Science:

• * Virology and Molecular Diagnostics
• * Immunology and Serological Assays

Background:

• * The COVID-19 pandemic presents a significant global health challenge, impacting multiple organs and causing respiratory illness.
• * Diagnostic laboratories are crucial for identifying SARS-CoV-2 using molecular and serological methods.

Purpose of the Study:

• * To compare various laboratory diagnostic assays for COVID-19.
• * To evaluate the roles of molecular and serological tests in disease diagnosis and management.

Main Methods:

• * Review of molecular-based techniques for SARS-CoV-2 detection.
• * Analysis of serological assays (IgM, IgA, IgG) for antibody detection and their timelines.
• * Comparison of sensitivity, cost, and speed of different diagnostic approaches.

Main Results:

• * Molecular tests offer reliable early-stage SARS-CoV-2 diagnosis.
• * Serological assays detect antibodies 3-18 days post-symptom onset and are useful for verifying asymptomatic infections, vaccine efficacy, and seroprevalence studies.
• * Serological tests are low-cost and fast but have limited sensitivity in early infection stages.

Conclusions:

• * Molecular diagnostics are vital for active COVID-19 case identification.
• * Serological tests are valuable for assessing immunity, confirming late cases, and epidemiological surveillance.
• * A combination of diagnostic methods provides comprehensive COVID-19 management.